What is the recommended Eliquis dosage for pulmonary embolism in adults under medical care?

According to available guidelines, the typical Eliquis dosage for treating pulmonary embolism (PE) in adults under medical supervision starts at 10 mg twice daily for 7 days, followed by 5 mg twice daily thereafter. Always consult with your healthcare provider before beginning a new medicine. 

Why Eliquis dosage for PE matters

People diagnosed with a pulmonary embolism often require anticoagulant treatment to reduce the risk of further clots and complications. Understanding the correct dosage helps ensure both safety and effectiveness.

• The dosage may differ depending on the treatment stage
• Ongoing risk factors can influence duration and dose
• Medical oversight is essential due to bleeding risks

This helps explain why individualized dosing with Eliquis is crucial.

How Eliquis treats pulmonary embolism

How it works

Eliquis may work by selectively inhibiting Factor Xa, an enzyme that plays a central role in the blood clotting cascade.

This targeted action reduces the blood’s ability to form new clots and may help prevent existing clots from growing larger.

Clinical applications

Eliquis is used to treat acute pulmonary embolism and deep vein thrombosis, as well as to reduce the risk of recurrent events. Patients usually begin intensive therapy quickly after diagnosis.

Over time, dosing may be adjusted based on risk assessments and physician evaluation.

Safety and Effectiveness

Safety profile

According to the Mayo Clinic, potential side effects of Eliquis include bleeding complications, such as nosebleeds, bruising more easily, or gastrointestinal bleeding.

Patients should report unusual symptoms to their healthcare provider and avoid other medications that increase bleeding risk unless advised otherwise.

FDA approval and indications

Eliquis (apixaban) is FDA-approved for the treatment of pulmonary embolism and deep vein thrombosis in adults, among other uses.

Always follow dosing instructions prescribed by your healthcare provider to ensure its safe and effective use.

Access and Availability

How to obtain safely

Patients can access Eliquis with a valid prescription through licensed pharmacies, including online providers like IsraelPharm, which offers guidance for PE and blood clot management.

Consult your healthcare provider before starting or adjusting any anticoagulant therapy.

Key Takeaways

• The initial recommended dosage for PE is 10 mg twice daily for 7 days, followed by 5 mg twice daily
• Eliquis works by inhibiting Factor Xa, helping reduce clot formation
• It’s prescribed for PE, DVT, and prevention of recurrence
• Potential side effects include increased bleeding risk
• Always follow your provider’s guidance and obtain Eliquis from certified pharmacies

FAQ

How long do I need to take Eliquis after a PE diagnosis?

Treatment typically includes 7 days of 10 mg twice daily, followed by 5 mg twice daily. Your provider may adjust the duration based on recurrence risk and individual health factors.

Is the dosage for Eliquis the same for DVT and PE?

Yes, the dosing regimen for treatment of both DVT and PE is the same: an initial 10 mg twice daily for 7 days, then 5 mg twice daily.

Can I travel while taking Eliquis after a PE?

It’s generally safe to travel, but special precautions should be taken when flying or inactive for long periods. Tips for traveling on Eliquis are available online.

Could switching dosages increase bleeding risk?

Transition periods between dosages may carry altered risk, so it’s important to follow instructions exactly and consult a doctor before making any changes.

Where can I learn more about stroke and clot prevention strategies?

This guide from IsraelPharm offers useful insight into stroke prevention, especially for those with clotting risks.